CAPITAL MANAGEMENT CORP /VA – Anika Therapeutics, Inc. Transaction History
CAPITAL MANAGEMENT CORP /VA portfolio value:
$2.43M
portfolio value
CAPITAL MANAGEMENT CORP /VA quarter portfolio value change:
+6.63%
quarter
Anika Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -62.78% | -172.74K shares | -3.70M | $23.8 | 102.39K |
Q2 2022 | share | Increase | +36.03% | 72.87K shares | 1.06M | $22.32 | 275.13K |
Q1 2022 | share | Increase | +52.25% | 69.40K shares | 319K | $25.11 | 202.25K |
Q4 2021 | share | Increase | +12.12% | 14.36K shares | -283K | $36.38 | 132.85K |
Q3 2021 | share | Increase | +19.32% | 19.18K shares | 744K | $42.56 | 118.49K |
Q2 2021 | share | Decrease | -31.66% | -46.00K shares | -1.62M | $43.29 | 99.30K |
Q1 2021 | share | Increase | +56.19% | 52.27K shares | 1.71M | $40.79 | 145.31K |
Q4 2020 | share | Decrease | -1.89% | -1.79K shares | 855K | $45.26 | 93.03K |
Q3 2020 | share | Decrease | -47.07% | -84.32K shares | -3.40M | $35.39 | 94.83K |
Q2 2020 | share | Increase | +92.83% | 86.24K shares | 4.07M | $37.73 | 179.15K |
Q1 2020 | share | Increase | +86.89% | 43.19K shares | 108K | $28.91 | 92.90K |
Q4 2019 | share | Increase | +1.78% | 870 shares | -103K | $51.85 | 49.71K |
Q3 2019 | share | Decrease | -31.66% | -22.62K shares | -222K | $54.89 | 48.84K |
Q2 2019 | share | Decrease | -36.18% | -40.52K shares | -484K | $40.62 | 71.47K |
Q1 2019 | share | Increase | +10.00% | 10.17K shares | -35K | $30.24 | 111.99K |
Q4 2018 | share | Increase | +27.23% | 21.79K shares | 47K | $33.61 | 101.81K |
Q3 2018 | share | Decrease | -37.84% | -48.71K shares | -745K | $42.18 | 80.02K |
Q2 2018 | share | Increase | +82.82% | 58.31K shares | 619K | $32 | 128.73K |
Q1 2018 | share | Increase | +15.28% | 9.33K shares | 208K | $49.72 | 70.41K |
Q4 2017 | share | Decrease | -0.47% | -290 shares | -267K | $53.91 | 61.08K |
Q3 2017 | share | Increase | +0.57% | 345 shares | 549K | $58 | 61.37K |
Q2 2017 | share | Decrease | -58.07% | -84.51K shares | -3.31M | $49.34 | 61.03K |
Q1 2017 | share | Decrease | -7.23% | -11.34K shares | -1.35M | $43.44 | 145.54K |
Q4 2016 | share | Increase | +14.56% | 19.94K shares | 1.12M | $48.96 | 156.88K |
Q3 2016 | share | Decrease | -25.97% | -48.04K shares | -3.37M | $47.85 | 136.94K |
Q2 2016 | share | Decrease | -12.60% | -26.67K shares | 459K | $53.65 | 184.98K |
Q1 2016 | share | Increase | +124.62% | 117.43K shares | 5.86M | $44.72 | 211.66K |